Neuroinfection survey at a neurological ward in a Brazilian tertiary teaching hospital

Carregando...
Imagem de Miniatura
Citações na Scopus
8
Tipo de produção
article
Data de publicação
2011
Título da Revista
ISSN da Revista
Título do Volume
Editora
HOSPITAL CLINICAS, UNIV SAO PAULO
Citação
CLINICS, v.66, n.6, p.1021-1025, 2011
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
OBJECTIVES: This study was undertaken to characterize the neuroinfection profile in a tertiary neurological ward. INTRODUCTION: Neuroinfection is a worldwide concern and bacterial meningitis, tetanus and cerebral malaria have been reported as the commonest causes in developing countries. METHODS: From 1999 to 2007, all patients admitted to the Neurology Ward of Hospital das Clinicas, Sao Paulo University School of Medicine because of neuroinfection had their medical records reviewed. Age, gender, immunological status, neurological syndrome at presentation, infectious agent and clinical outcome were recorded. RESULTS: Three hundred and seventy four cases of neuroinfectious diseases accounted for 4.2% of ward admissions and the identification of infectious agent was successful in 81% of cases. Mean age was 40.5 +/- 13.4 years, 63.8% were male, 19.7% were immunocompromised patients and meningoencephalitis was the most common clinical presentation despite infectious agent. Viruses and bacteria were equally responsible for 29.4% of neuroinfectious diseases; parasitic, fungal and prion infections accounted for 28%, 9.6% and 3.5% respectively. Human immunodeficiency virus (HIV), herpes simplex virus 1 (HSV1), Mycobacterium tuberculosis, Treponema pallidum, Taenia solium, Schistosoma mansoni, Cryptococcus neoformans and Histoplasma capsulatum were the more common infectious pathogens in the patients. Infection mortality rate was 14.2%, of which 62.3% occurred in immunocompetent patients. CONCLUSION: Our institution appeared to share some results with developed and developing countries. Comparison with literature may be considered as quality control to health assistance.
Palavras-chave
Infectious Diseases, Nervous System, Tropical Medicine, Epidemiology, Neurology
Referências
  1. Garcia HH, 2003, LANCET, V362, P547, DOI 10.1016/S0140-6736(03)14117-7
  2. Hopkins DR, 2008, ANN NY ACAD SCI, V1136, P45, DOI 10.1196/annals.1425.015
  3. Prasad KN, 2008, J BIOSCIENCES, V33, P571, DOI 10.1007/s12038-008-0075-y
  4. Steiner I, 2005, EUR J NEUROL, V12, P331, DOI 10.1111/j.1468-1331.2005.01126.x
  5. Hatz CFR, 2005, J TRAVEL MED, V12, P1
  6. Hotez PJ, 2009, BIOLOGICALS, V37, P160, DOI 10.1016/j.biologicals.2009.02.008
  7. Wadhwa A, 2008, NEUROLOGIST, V14, P247, DOI 10.1097/NRL.0b013e3181678a7a
  8. Mata-Essayag S, 2008, MEDICINE, V87, P193, DOI 10.1097/MD.0b013e31817fa2a8
  9. Tan K, 2008, NEUROLOGY, V71, P1160, DOI 10.1212/01.wnl.0000327526.71683.b7
  10. Marchiori PE, 2007, J HEART LUNG TRANSPL, V26, P1091, DOI 10.1016/j.healun.2007.07.043
  11. Chapp-Jumbo Emmanuel N, 2006, Afr Health Sci, V6, P55
  12. de Andrade DC, 2007, NEUROLOGY, V69, pE12, DOI 10.1212/01.wnl.0000277047.22403.8d
  13. GARDNER E, 1993, PERIPHERAL NEUROPATH, P8
  14. Goldstein W, 2007, EUR J INTERN MED, V18, P504, DOI 10.1016/j.ejim.2007.02.017
  15. Jaren O, 2006, NEUROLOGIST, V12, P245, DOI 10.1097/01.nrl.0000240859.97587.48
  16. Jmor F, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-134
  17. King Charles H, 2008, Chronic Illn, V4, P65, DOI 10.1177/1742395307084407
  18. Krcmery V, 2007, NEUROENDOCRINOL LETT, V28, P5
  19. NGAMBI S, 2007, NEURO ENDOCRINOL LET, V28, P25
  20. Shears P, 2007, J HOSP INFECT, V67, P217, DOI 10.1016/j.jhin.2007.08.016
  21. Soumare M, 2005, MED MALADIES INFECT, V35, P383, DOI 10.1016/j.medmal.2005.03.009
  22. Sundaram C, 2006, HISTOPATHOLOGY, V49, P396, DOI 10.1111/j.1365-2559.2006.02515.x
  23. TALABI AO, 2003, W AFR J MED, V22, P150
  24. VERMA A, 2007, NEUROLOGY CLIN PRACT, P1473